• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonamides

1-(4-Bromophenylsulfonyl)pyrrolidine: A Comprehensive Overview

1-(4-Bromophenylsulfonyl)pyrrolidine (CAS No. 136350-52-2) is a sophisticated organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmacology. This compound, characterized by its unique structure featuring a pyrrolidine ring substituted with a sulfonyl group attached to a bromophenyl moiety, has demonstrated potential in various therapeutic applications. Recent studies have highlighted its role in modulating cellular signaling pathways, making it a promising candidate for drug development.

The synthesis of 1-(4-Bromophenylsulfonyl)pyrrolidine involves a multi-step process that combines principles of organic chemistry, including nucleophilic aromatic substitution and sulfonation reactions. Researchers have optimized these methods to achieve higher yields and better purity, ensuring the compound's reliability for downstream applications. The use of advanced spectroscopic techniques, such as NMR and mass spectrometry, has further facilitated the characterization of this compound, confirming its structural integrity and stability under various conditions.

One of the most intriguing aspects of 1-(4-Bromophenylsulfonyl)pyrrolidine is its pharmacokinetic profile. Studies conducted in preclinical models have revealed favorable absorption and bioavailability, suggesting that it could be effectively administered orally. Additionally, the compound exhibits selective binding to specific receptors, which is critical for minimizing off-target effects and enhancing therapeutic efficacy. These findings underscore its potential as a lead compound in the development of novel therapeutics targeting diseases such as cancer and inflammatory disorders.

Recent advancements in computational chemistry have enabled researchers to perform detailed molecular docking studies on 1-(4-Bromophenylsulfonyl)pyrrolidine. These studies have provided insights into its interaction with key proteins involved in cellular signaling, such as kinases and G-protein coupled receptors (GPCRs). The results indicate that the compound's sulfonyl group plays a pivotal role in stabilizing these interactions, thereby enhancing its potency and selectivity.

In terms of applications, 1-(4-Bromophenylsulfonyl)pyrrolidine has shown promise in the development of anti-inflammatory agents. Preclinical trials have demonstrated its ability to inhibit pro-inflammatory cytokines, such as TNF-alpha and IL-6, which are key mediators of inflammatory responses. Furthermore, the compound has exhibited anti-proliferative effects on various cancer cell lines, suggesting its potential role in oncology.

The environmental impact of 1-(4-Bromophenylsulfonyl)pyrrolidine is another area of growing interest. Researchers have investigated its biodegradability and toxicity profiles under controlled conditions. Initial findings indicate that the compound undergoes rapid metabolic degradation in aqueous environments, reducing its ecological footprint. However, further studies are required to fully assess its long-term environmental implications.

In conclusion, 1-(4-Bromophenylsulfonyl)pyrrolidine (CAS No. 136350-52-2) represents a cutting-edge molecule with diverse applications in drug discovery and development. Its unique chemical structure, coupled with favorable pharmacokinetic properties and potent biological activity, positions it as a valuable tool for addressing unmet medical needs. As research continues to uncover new insights into its mechanisms of action and therapeutic potential, this compound is poised to make significant contributions to the field of medicinal chemistry.

• 867332-75-0(4-Bromo-N-ethyl-N-(2-pyrrolidin-1-yl-ethyl)-benzenesulfonamide)
• 214210-14-7(1-(3-Bromophenylsulfonyl)pyrrolidine)
• 871269-12-4(1-(3-Bromophenylsulfonyl)piperidine)
• 834-66-2(1-(4-Bromophenylsulfonyl)piperidine)
• 1133116-31-0(1,5-bis(3-Bromophenylsulfonyl)-1,5-diazocane)
• 867333-27-5(4-Bromo-N-methyl-N-(2-pyrrolidin-1-yl-ethyl)-benzenesulfonamide)
• 929000-58-8(1-(2-Bromophenylsulfonyl)pyrrolidine)
• 5033-22-7(1-(Phenylsulfonyl)pyrrolidine)
• 153439-48-6(1-(4-Bromobenzene)sulfonylhomopiperidine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)